Jack Scanlan

Jack Scanlan

Auto-generated profile, based on publicly available information

Jack Scanlan

Mass Spectrometry & Proteomics Group, Centre for Pharmaceutical Innovation, College of Health, Adelaide University, Adelaide, South Australia, Australia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2025 in Journal of Proteome Research
Verified
Journal Article
Closed access
JSJack Scanlan
Jack Scanlan
PMParul Mittal
Parul Mittal
NLNoor A. Lokman
Noor A. Lokman
MOMartin K. Oehler
Martin K. Oehler
PHPeter Hoffmann
Peter Hoffmann
MKManuela Klingler-Hoffmann
Manuela Klingler-Hoffmann

28 January 2026 in Journal of Proteome Research
Verified
Journal Article
Closed access
JSJack Scanlan
Jack Scanlan
PMParul Mittal
Parul Mittal
MOMartin K. Oehler
Martin K. Oehler
PHPeter Hoffmann
Peter Hoffmann
MKManuela Klingler-Hoffmann
Manuela Klingler-Hoffmann

2 January 2026 in Science Advances
Verified
Journal Article
Open access
LDLoretta Dorstyn
Loretta Dorstyn
YLYoon Lim
Yoon Lim
JSJack Scanlan
Jack Scanlan
EMEmma McLennan
Emma McLennan
DBDylan De Bellis
Dylan De Bellis
SKSharad Kumar
Sharad Kumar
Hepatocyte polyploidization promotes liver homeostasis by enhancing resistance to cellular stress. Caspase-2, a proapoptotic protease, restricts polyploidization by deleting polyploid and aneuploid cells. While caspase-2 protects against diet-induced hepatic injury, it also acts as a tumor suppressor by controlling genomic instability and oxidative stress. To investigate these roles, we assessed hepatic ploidy dynamics, liver damage, and age-associated tumorigenesis in caspase-2–deficient and catalytically inactive mutant mice. We found that caspase-2 loss promotes early-onset hepatocyte hyperpolyploidy, accompanied by progressive liver inflammation, fibrosis, oxidative liver damage, ferroptosis, and higher incidence of spontaneous hepatocellular carcinoma in aged animals. Proteomic profiling revealed a pathogenic polyploidy–associated signature associated with caspase-2 deficiency and increased predisposition to liver disease and malignancy. These findings establish caspase-2 enzymatic activity as a critical regulator of hepatic genome stability and preventing age-related liver cancer that strongly argue against therapeutic caspase-2 inhibition as a strategy for managing liver injury or cancer risk.

11 May 2026 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
WLWai Chuen Darren Lau
Wai Chuen Darren Lau
PMParul Mittal
Parul Mittal
JSJack Scanlan
Jack Scanlan
LDLeigh Donnellan
Leigh Donnellan
MKManuela Klingler-Hoffmann
Manuela Klingler-Hoffmann
PHPeter Hoffmann
Peter Hoffmann
The metabolic architecture of oat grains remains poorly understood at the cellular and proteome levels despite increasing interest for applications such as nutritional enhancement and functional crop improvement. In this study, we performed matrix-assisted laser desorption and ionization mass spectrometry imaging (MALDI-MSI) to map metabolite distributions across oat grain tissues and delineate major compartments of metabolite localization. These metabolite-rich regions, notably the bran, endosperm, and embryo, were then isolated for proteomic analysis, which detected around 3700 proteins across all tissue types. Gene ontology analysis highlighted specialized functions and biological processes associated with each compartment. Further interrogation of key proteins revealed the enrichment of core cellular functions such as energy generation, translation, and stress resilience in the embryo, nutrient storage in the endosperm, and an intermediate functional profile in the bran. These findings provide new insights into the spatial organization of metabolic functions within oat grains and warrant further exploration of sub-regions for a deeper understanding of the oat metabolic architecture. Graphical Abstract

28 June 2026 in Clinical Proteomics
Verified
Journal Article
Open access
JSJack Scanlan
Jack Scanlan
PMParul Mittal
Parul Mittal
JWJennifer Washington
Jennifer Washington
CYClifford Young
Clifford Young
MAMichael Antoniou
Michael Antoniou
MKManuela Klingler-Hoffmann
Manuela Klingler-Hoffmann
Most advanced ovarian cancer patients develop malignant ascites, which describes a buildup of fluid in the peritoneal cavity caused by increased vascular permeability and obstructed lymphatic drainage. Malignant ascites contains cancer cells, which can aggregate as spheroids, as well as stromal cells, cancer-associated fibroblasts, and blood cells that create a complex tumor microenvironment. This study explores the proteome of ascites and how this environment affects the viability, phenotypes, proteomes, and treatment responses of ovarian cancer cells. Using label-free proteomics, we compared the proteomes of cell-free malignant ascites from ovarian cancer patients with those of serum. Additionally, we examined the ex vivo chemotherapy responses of cancer spheroids cultured in ascites. Through detailed proteomic analysis of cells grown as 2D or 3D in tissue culture medium or ascites, we identified biological pathways and specific proteins induced by ascites. Finally, we performed orthogonal validation of a candidate marker, TGM2, using immunofluorescent staining. Proteomics of cell-free ascites identified increased levels of extracellular, secreted, and membrane proteins when compared to serum. Ascites enhanced the baseline cell viability and spheroid formation of immortalized ovarian cancer cell lines compared to standard cell culture medium. However, chemotherapy-induced cell death of spheroids grown in standard cell culture medium remained proportional to changes observed in ascites-cultured spheroids. Ascites-driven phenotypic changes were not recapitulated by adding selected chemokines nor periostin to the cell culture medium, suggesting that additional factors are required. Notably, ascites induced similar ECM, secreted, and membrane proteins across 2D and 3D models, including TGM2, which was validated in spheroids through immunofluorescent staining. This study contributes to our understanding of the role of ascites in the regulation of the proteome and viability of cancer cells. It provides evidence for the induction of TGM2 expression by ascites. Results from this pilot study warrant further study in a larger cohort.

15 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJack Scanlan
Jack Scanlan
PMParul Mittal
Parul Mittal
JWJennifer Washington
Jennifer Washington
CYClifford Young
Clifford Young
MOMartin K Oehler
Martin K Oehler
MKManuela Klingler-Hoffmann
Manuela Klingler-Hoffmann
Background: More than 90% of advanced ovarian cancer patients develop malignant ascites, which describes a buildup of fluid in the peritoneal cavity caused by increased vascular permeability and obstructed lymphatic drainage. Malignant ascites contains spheroidal tumor cell clusters that contain stromal cells, cancer-associated fibroblasts, and blood cells. These spheroids promote peritoneal metastasis and treatment resistance, yet the phenotypic and proteomic changes of cells caused by the ascites environment remain poorly understood, as does its influence on ex vivo responses to chemotherapeutics in personalized medicine approaches. Methods: Using mass spectrometry, we compared the proteome profiles of cell-free ascites to serum from ovarian cancer patients. We then analyzed the proteomes of immortalized cancer cells grown as monolayers or spheroids in either malignant ascites or standard cell culture medium. The effects of this fluid on the phenotype, molecular composition, and ex vivo chemotherapy responses of cancer cells were also investigated. Results: Proteome analysis revealed that cell-free ascites had higher levels of extracellular, secreted, and membrane proteins compared to serum. Ascites enhanced cell viability and spheroid formation in immortalized ovarian cancer cell lines more effectively than standard cell culture medium. Despite this altered baseline viability, growth of spheroids in ascites versus cell culture medium did not hinder chemotherapy response assessments, indicating the appropriateness of standard cell culture medium in ex vivo applications. The observed phenotypic changes of cells grown in ascites could not be recapitulated by adding chemokines or periostin to the cell culture medium, suggesting that additional factors are required. Notably, elevated levels of transglutaminase 2 were identified in SKOV-3 cells grown in ascites, indicating that ascites directly influences protein expression in cancer cells.